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(AE) during PBSC mobilization and collection. AE included
weight gain greater than 2%, cardiac arrhythmias/events,
hemorrhagic or thromboembolic events, failure to complete
PBSC collection, and death.
Results: The median age of patients was 60 years and me-
dian serum creatinine was 1.09 mg/dL. Fifteen patients (15%)
had cardiac involvement, 45 patients (45%) had renal
involvement, and 21 patients (21%) had both cardiac and
renal amyloid involvement. Ninety-two patients (91%) suc-
cessfully collected a minimum of 2 x 106 CD34 cells/kg and
proceeded to auto-HCT. Nine patients (9%) failed to com-
plete initial PBSC mobilization attempt due to signiﬁcant
toxicity and 7 patients (7%) were never able to proceed to
auto-HCT. Four patients (4%) died during the peri-mobili-
zation period, with 3 deaths attributed to sepsis/multi-or-
gan failure. Sixty-one patients (60%) developed weight gain
>2% of baseline weight. Seven patients (7%) experienced a
cardiac event (5 atrial ﬁbrillation/tachyarrhythmias, 1
myocardial infarction, and 1 hypertensive urgency). Five
patients (5%) had a thromboembolic event (4 deep venous
thromboses and 1 pulmonary embolism). Three patients
(3%) developed a signiﬁcant bleeding event (1 central ner-
vous system and 2 gastrointestinal). Because of high risk for
complications during PBSC mobilization, 17 patients (17%)
underwent PBSC mobilization as an inpatient. Furthermore,
14 patients (14%) began the mobilization process as an
outpatient but were subsequently admitted for
complications.
Conclusion: PBSC mobilization and collection in AL patients
can be associated with signiﬁcant morbidity, with almost
10% of patients unable to complete collection, and peri-
mobilization mortality of almost 4%. Selected patients may
beneﬁt from hospitalization during PBSC mobilization and
collection.TRANSPLANT NURSING ADMINISTRATION549
Shared Leadership: Clinical Nurse Leaders Improving
Continuity of Care and Quality Outcomes for Hospitalized
Stem Cell Transplant Patients
Roxann Blackburn 1, Kelly Brassil 2. 1 HSCTCT, UT MD
Anderson Cancer Center, Houston, TX; 2 Nursing
Administration, University of Texas at MD Cancer Center,
Houston, TX
Topic Signiﬁcance & Study Purpose/Background/Rationale:
As increasingly more complex hematopoietic stem cell
transplants (HSCT) are performed there is a need to
improve continuity of care and quality outcomes for in-
patients. A shared leadership approach was use to on-board
four Clinical Nurse Leaders (CNLs) to a 48-bed HSCT unit in
a novel patient care delivery system as part of an institu-
tional roll out. Each CNL functioned as the primary lead
over staff and patients assigned to 12-bed pods in a patient-
centered care delivery approach called Primary Team
Nursing (PTN). The purpose is to discuss nurse sensitive
quality and patient satisfaction outcomes following the
implementation of PTN using CNLS on a large inpatient
stem cell transplant unit.
Methods, Intervention, & Analysis: Four CNLs trained with
bedside nurses learning the care of HSCT patients on a 48-bed unit over a 3-month period, and were then moved into
the CNL role overseeing teams of nurses and assistants
working on 12-bed pods with the implementation of PTN.
Quality and patient satisfaction data were trended prior to
and following the implementation of PTN. Additionally team
based outcomes were evaluated using TeamSTEPPS assess-
ment tools.
Findings & Interpretation: Metrics indicate signiﬁcant im-
provements in most nurse sensitive quality indicators
including patient satisfaction, fall reduction, hourly round-
ing, and CLABSI. Additionally TeamSTEPPS assessments per-
formed at intervals throughout the ﬁrst year of
implementation show improvement across the domains of
team structure, leadership, mutual support and
communication.
Discussion & Implications: Using CNLs as the team leader in
the Primary Team Nursing Model may contribute to
enhancing quality and continuity of care for complex HSCT
patients.550
Innovative Patient and Family Education
Ann Breen. Patient and Family Education, Seattle Cancer Care
Alliance, Seattle, WA
Topic Signiﬁcance & Study Purpose/Background/
Rationale: The shift of responsibilities to the outpatient
arena for patients and caregivers has challenged educators to
expand information accessibility from onsite education to
easily accessible internet resources. Effective education
keeps patients safe by providing caregivers speciﬁc infor-
mation when needed. Caregivers expect to get the trust-
worthy information from doctors and nurses as well as
online. Most caregivers have mobile devices (Pew 2013) and
increasingly rely upon the internet for information (Longa-
cre, 2013).
Methods, Intervention, & Analysis: Ongoing pre/post
Program Evaluation surveys are available. We developed a
multiplatform strategy utilizing social media (Facebook),
online video library, live streaming classes, online patient
manuals, and a RN monitored phone line in addition to
traditional formats such as a foundation class focusing on
post-transplant in the home. This approach provides ac-
cess to speciﬁc personalized information anywhere. These
approaches allow accessibility unimaginable a few years
ago.
Online distribution of patient manuals ensures current
information at home. Video links are contained in online
manuals. The core transplant videos include clinic orienta-
tion, managing care at home, CVC care, donor information,
long-term follow up, food safety, and relaxation. There are
over 70 videos in the online library. Patients and families use
the videos in anticipation of treatment as well as for review
of material.
Findings & Interpretation: The presentation will include
data from three sources: Facebook analytics (3000 monthly
interactions), ongoing surveys from program evaluations and
from a research protocol. Survey comments like “have PDFs
of caregiver manuals online” and “have videos online”
guided development. Results indicate preference for
personalized RN/MD instruction, classes, andmanuals (>4.5/
5) over generic pamphlets (3.7/5). Many patients have
rotating caregivers or out of town family members who rely
upon online materials.
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multiplatform model which addresses the growing com-
puter literacy of patients while simultaneously assisting low
literacy patients.551
Outcomes Resilience after System Stress: A Rapid-Cycle
Response to Mitigate the Impact of Care Delivery System
Stress on Primary Blood Stream Infections
Laura Flesch 1, Deanna Hawkins 2,
Kathleen Marie Demmel 3, Jackie Hausfeld 4,
Stella M. Davies 1, Christopher E. Dandoy 1. 1 Bone Marrow
Transplantation and Immune Deﬁciency, Cincinnati Children’s
Hospital Medical Center, Cincinnati, OH; 2Hematology/
Oncology, Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH; 3 Cancer and Blood Diseases Institute,
Cincinnati Children’s Hospital, Cincinnati, OH; 4 Cincinnati
Children’s Hospital Medical Center, Cincinnati, OH
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Immunocompromised children are at high risk for primary
blood stream infections (BSI) and the associated morbidity
and mortality. Prevention of BSIs depends on highly reliable
care. The purpose of our study was to rapidly mitigate the
impact of system stress on the rate of BSIs in a high risk
population.
Methods, Intervention, & Analysis: After a dramatic in-
crease in patient volume and acuity coupled with an increase
in new and ﬂoat nurse staff at a large, quaternary children’s
medical center, BSI rates more than doubled. A failure-mode
analysis of key processes identiﬁed poor adherence to daily
hygiene guidelines, high rates of nurses requiring assistance
to complete high BSI-risk procedures, and an unreliable
system to escalate concerns from the bedside to unit lead-
ership. Iteratively implemented mitigation strategies
included a standard process to improve daily hygiene
adherence, increased awareness of high BSI-risk patients,
assistance for nurses performing high BSI-risk procedures,
and improved allocation of resources to deescalate system
stress.
Findings & Interpretation: Since the mitigation strategies
were fully implemented there have been no further BSIs in
>100 days (6000 line days). Key processes have become
more reliable: 100% of dressing changes are completed with
the new, 2 person standard; daily hygiene adherence has
increased from 25% to 70%; 100% of bedside nurses are
approached daily by nurse unit leaders to identify and plan
for patients at risk for a BSI.
Discussion & Implications: Stress to a complex care
delivery system for high-risk patients can degrade BSI
rates. Rapidly identifying failures in key processes and
improving their reliability can quickly stabilize out-
comes.552
Impact of Addition of Alcohol-Impregnated Port
Protectors to Post Central Line Insertion Bundle in the
Adult Blood and Marrow Transplant Population
Angela Nooner 1, Tamara Walker 2, Nicholas Shepherd 2. 1 OU
Medical System, Oklahoma City, OK; 2 Adult Oncology, OU
Medical System, Oklahoma City, OK
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Central venous catheters (CVC) are a commonly used tool in
hematopoietic stem cell transplant (HSCT). Several risks are
associated with the use of CVCs including infection and
thrombosis. The incidence of blood stream infection in HSCT
recipients has been observed at 13-60% (Dix, Yeung, Rule &
Ma, 2011). Poutsiaka et al. (2007) found that blood stream
infection was independently associated with increased mor-
tality after HSCT. On average a CLABSI increases a patient’s
length of stay by 7.5 days and costs $16,550 to treat (Sacks et
al., 2014).
In NHSN’s 2012 summary of device-associated infections,
the median CLABSI rate for the more than 178 participating
general hematology oncology facilities was 0.8 for perma-
nent central lines and 1.2 for temporary central line cathe-
ters. The median was 1.3 and 2.4 for more than 54
participating hematopoietic stem cell transplant units.
OUMC’s CLABSI data does not differentiate between perma-
nent and temporary central lines, but the CLABSI rates during
the six month control period were higher than the national
median for the two types of lines combined. Between July 1,
2013 and December 31, 2013, nine CLABSIs occurred in the
Bone Marrow Transplant Unit, a CLABSI rate of 10.5/1,000
central line days.
Methods, Intervention, & Analysis: An interdisciplinary
team developed an intervention to reduce the number of
CLABSIs in the Adult Blood and Marrow Transplant Unit,
in addition to the standard central line maintenance
bundle.
An observational pre-intervention/post-intervention trial
was conducted in an adult blood and marrow transplant unit
university-afﬁliated acute care teaching hospital. During the
intervention alcohol-impregnated port protectors were used
in place of alcohol wipes for hub care. The intervention
period was compared with a historical control.
Findings & Interpretation: A total of 466 central line days
and 1 CLABSI were documented during the intervention
period, compared with 762 central line days and 9 CLABSIs
during the control period.
Discussion & Implications: The addition of alcohol-
impregnated port protectors to central line maintenance can
assist in reduction of CLABSI incidence in the blood and
marrow transplant population, which should reduce the
morbidity and mortality associated with infection in the
immune-compromised patient.
